Titel: Biomarkers for Brain Disorders: Challenges and Opportunities

Termin: 27.2.2011 bis 2.3.2011

Veranstaltungsort:
Wellcome Trust Conference Centre
Hinxton
Saffron Walden
Essex CB10 1RQ
United Kingdom

Weitere Informationen:
https://registration.hinxton.wellcome.ac.uk/display_info.asp?id=223

Kurzbeschreibung: The discovery and validation of biomarkers in neurological and neurodegenerative diseases is an important challenge for early diagnosis of disease and for the development of therapeutics. This new Wellcome Trust Scientific Conference will bring together leading neuroscientists from academia and industry involved in genomics, proteomics, diagnostics, imaging and regulatory affairs. The meeting will discuss methodological aspects of biomarker identification across a spectrum of psychiatric and neurodegenerative disorders, strategies for diagnostic assay development and pathways for regulatory approval.

Kontakt: Hinxton
Saffron Walden
Essex CB10 1RQ
United Kingdom
Tel.: 0044 -1223 - 495100
scientificconferences@ hinxton.wellcome.ac.uk
https://registration.hinxton.wellcome.ac.uk/display_info.asp?id=223

Veranstalter: Wellcome Trust

Wissenschaftliche Leitung: Andreas Jeromin, Banyab Biomarkers, USA, Andy Lockhart, GlaxoSmithKline, UK, Simon Lovestone, Kings College London, UK, William Potter, formerly Merck, Inc., USA

Schlagworte: Forschungsethik, Hirnforschung, Krankheit, Medizinische Ethik, Psychiatrie